Preventing bone loss in renal transplant recipients with vitamin D.

Abstract

Very rapid bone loss, osteopenia, and osteoporosis have been documented in the first 6 to 12 mo after renal transplantation. Investigated was the effect of treatment with active vitamin D on the prevention of posttransplantation bone loss. Forty adult men who were recent renal transplant recipients were enrolled onto the study. Patients were randomized into two groups: group 1 received daily alfacalcidol 0.5 micro g by mouth, and group 2 (control) received placebo. Every patient in both groups received daily 500-mg calcium carbonate supplements. Parameters of bone metabolism and bone mineral density measured at three sites were assessed before and after the study period. Bone mineral density was increased by 2.1%, 1.8%, and 3.2% at lumbar spine, femoral neck, and forearm, respectively, in group 1, whereas it decreased by 3.2%, 3.8%, and 1.8% at the same sites in the control group (P < 0.05). Serum intact parathyroid hormone level decreased significantly in group 1 compared with the control group (P = 0.003). Early bone loss that occurs during the first 1 yr after renal transplantation could be prevented by alfacalcidol. Use of alfacalcidol early after transplantation is safe and well tolerated.

010002000'04'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

4,990 Citations

Semantic Scholar estimates that this publication has 4,990 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{ElAgroudy2003PreventingBL, title={Preventing bone loss in renal transplant recipients with vitamin D.}, author={Amgad El-Baz El-Agroudy and A El-Husseini and Moharam F El-Sayed and Mohamed A. Ghoneim}, journal={Journal of the American Society of Nephrology : JASN}, year={2003}, volume={14 11}, pages={2975-9} }